Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Shares, par value (euro)0.12 per share
-
Shares outstanding
-
22,421,536
-
Total 13F shares
-
257,246
-
Share change
-
+107,246
-
Total reported value
-
$1,083,006
-
Price per share
-
$4.21
-
Number of holders
-
2
-
Value change
-
+$451,506
-
Number of buys
-
2
Institutional Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) as of Q4 2023
As of 31 Dec 2023,
CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
257,246 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., MILLENNIUM MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Camber Capital Management LP, Alyeska Investment Group, L.P., Bill & Melinda Gates Foundation, CITADEL ADVISORS LLC, Walleye Capital LLC, and MORGAN STANLEY.
This page lists
87
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.